NF2 mutation screening by denaturing high-performance liquid chromatography and high-resolution melting analysis

Genetic Testing

Volumn 12, Issue 2, 2008, Pages 311-318

  Sestini, Roberta ^a,b   Provenzano, Aldesia ^a   Bacci, Costanza ^a   Orlando, Claudio ^a   Genuardi, Maurizio ^a   Papi, Laura ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Dipartimento di Fisiopatologia Clinica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; EXON; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE REARRANGEMENT; GENETIC PROCEDURES; GENETIC SCREENING; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR PROBE; MUTATIONAL ANALYSIS; NEUROFIBROMATOSIS; NEUROFIBROMATOSIS TYPE 2 GENE; POINT MUTATION; TUMOR SUPPRESSOR GENE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; EXONS; GENES, NEUROFIBROMATOSIS 2; HUMANS; NEUROFIBROMATOSIS 2; NEUROMA, ACOUSTIC; NUCLEIC ACID DENATURATION; POINT MUTATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSITION TEMPERATURE;

EID: 45549092891     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2007.0096     Document Type: Article

References (36)

1. Chou LS, Lyon E, Wittwer CT (2005) A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model. Am J Clin Pathol 124:330-338.
2. Dobrowolski SF, Ellingson CE, Caldovic L, Tuchman M (2007) Streamlined assessment of gene variants by high resolution melt profiling utilizing the ornithine transcarbamylase gene as a model system. Hum Mutat 28:1133-1140.
3. Dobson-Stone C, Cox RD, Lonie L, Southam L, Fraser M, Wise C, Bernier F, Hodgson S, Porter DE, Simpson AH, Monaco AP (2000) Comparison of fluorescent single-strand conformation polymorphism analysis and denaturing high-performance liquid chromatography for detection of EXT1 and EXT2 mutations in hereditary multiple exostoses. Eur J Hum Genet 8:24-32.
4. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Teare D, Newton V, Strachan T, Ramsden R, Harris R (1992) A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 29:841-846.
5. Evans DG, Ramsden R, Shenton A, Gokhale C, Bowers NL, Huson SM, Pichert G, Wallace A (2007) Mosaicism in NF2 an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including MLPA. J Med Genet 44:424-428.
6. Graham R, Liew M, Meadows C, Lyon E, Wittwer CT (2005) Distinguishing different DNA heterozygotes by high-resolution melting. Clin Chem 51:1295-1298.
7. Gross E, Arnold N, Goette J, Schwarz-Boeger U, Kiechle M (1999) A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Genet 105:72-78.
8. Hegde M, Blazo M, Chong B, Prior T, Richards C (2005) Assay validation for identification of hereditary nonpolyposis colon cancer-causing mutations in mismatch repair genes MLH1, MSH2, and MSH6. J Mol Diagn 7:525-534.
9. Jones AC, Sampson JR, Cheadle JP (2001) Low level mosaicism detectable by DHPLC but not by direct sequencing. Hum Mutat 17:233-234.
10. Jones AC, Sampson JR, Hoogendoorn B, Cohen D, Cheadle JP (2000) Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis. Hum Genet 106:663-668.
11. Kennerson ML, Warburton T, Nelis E, Brewer M, Polly P, de Jonghe P, Timmerman V, Nicholson GA (2007) Mutation scanning the GJB1 gene with high-resolution melting analysis: implications for mutation scanning of genes for Charcot-Marie-Tooth disease. Clin Chem 53:349-352.
12. Kluwe L, Mautner V, Heinrich B, Dezube R, Jacoby LB, Friedrich RE, MacCollin M (2003) Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J Med Genet 40:109-114.
13. Kluwe L, Nygren AO, Errami A, Heinrich B, Matthies C, Tatagiba M, Mautner V (2005) Screening for large mutations of the NF2 gene. Genes Chromosomes Cancer 42:384-391.
14. Krypuy M, Ahmed AA, Etemadmoghadam D, Hyland SJ, Group AO, Brenton JD, Fox SB, Defazio A, Bowtell DD, Dobrovic A (2007) High resolution melting for mutation scanning of TP53 exons 5-8. BMC Cancer 31:168-180.
15. Krypuy M, Newnham GM, Thomas DM, Conron M, Dobrovic A (2006) High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer. BMC Cancer 6:295-306.
16. Liew M, Pryor R, Palais R, Meadows C, Erali M, Lyon E, Wittwer C (2004) Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. Clin Chem 50:1156-1164.
17. Liu W, Smith DI, Rechtzigel KJ, Thibodeau SN, James CD (1998) Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res 26:1396-1400.
18. Margraf RL, Mao R, Highsmith WE, Holtegaard LM, Wittwer CT (2006) Mutation scanning of the RET protooncogene using high-resolution melting analysis. Clin Chem 52:138-141.
19. Margraf RL, Mao R, Highsmith WE, Holtegaard LM, Wittwer CT (2007) RET proto-oncogene genotyping using unlabeled probes, the masking technique, and amplicon high-resolution melting analysis. J Mol Diagn 9:184-196.
20. Marsh DJ, Theodosopoulos G, Howell V, Richardson AL, Benn DE, Proos AL, Eng C, Robinson BG (2001) Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high-performance liquid chromatography. Neoplasia 3:236-244.
21. Mautner VF, Lindenau M, Baser ME, Hazim W, Tatagiba M, Haase W, Samii M, Wais R, Pulst SM (1996) The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery 38:880-885.
22. Montgomery J, Wittwer CT, Kent JO, Zhou L (2007) Scanning the Cystic Fibrosis Transmembrane Conductance Regulator Gene Using High-Resolution DNA Melting Analysis. Clin Chem 53:1891-1898.
23. Moyhuddin A, Baser ME, Watson C, Purcell S, Ramsden RT, Heiberg A, Wallace AJ, Evans DG (2003) Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring. J Med Genet 40:459-463.
24. Nickerson ML, Weirich G, Zbar B, Schmidt LS (2000) Signature-based analysis of MET proto-oncogene mutations using DHPLC. Hum Mutat 16:68-76.
25. Pal T, Napierala D, Becker TA, Loscalzo M, Baldridge D, Lee B, Sutphen R (2007) The presence of germ line mosaicism in cleidocranial dysplasia. Clin Genet 71:589-591.
26. Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N (1994) Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52:450-461.
27. Reed GH, Kent JO, Wittwer CT (2007) High-resolution DNA melting analysis for simple and efficient molecular diagnostics. Pharmacogenomics 8:597-608.
28. Reed GH, Wittwer CT (2004) Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. Clin Chem 50:1748-1754.
29. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fahsold R, Dumanski J, de Jong P, Parry D, Eldridge R, Aurias A, Delattre O, Thomas G (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515-521.
30. Sestini R, Vivarelli R, Balestri P, Ammannati F, Montali E, Papi L (2000) Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother, and identification of seven novel mutations in the NF2 gene. Hum Genet 107:366-371.
31. Sevilla C, Moatti JP, Julian-Reynier C, Eisinger F, Stoppa-Lyonnet D, Bressac-de Paillerets B, Sobol H (2002) Testing for BRCA1 mutations: a cost-effectiveness analysis. Eur J Hum Genet 10:599-606.
32. Takano T, Ohe Y, Tsuta K, Fukui T, Sakamoto H, Yoshida T, Tateishi U, Nokihara H, Yamamoto N, Sekine I, Kunitoh H, Matsuno Y, Furuta K, Tamura T (2007) Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib. Clin Cancer Res 15:5385-5390.
33. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800.
34. Underhill PA, Jin L, Lin AA, Mehdi SQ, Jenkins T, Vollrath D, Davis RW, Cavalli-Sforza LL, Oefner PJ (1997) Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography. Genome Res 7:996-1005.
35. Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ (2003) High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 49:853-860.
36. Wu G, Wu W, Hegde M, Fawkner M, Chong B, Love D, Su LK, Lynch P, Snow K, Richards CS (2001) Detection of sequence variations in the adenomatous polyposis coli (APC) gene using denaturing high-performance liquid chromatography. Genet Test 5:281-290.